LIFEVANTAGE CORP Form NT 10-Q: Notification of late filing: quarterly report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2016-11-10: Form NT 10-Q; Period of report 2016-09-30; Description NT 10-Q; Document lfvnform12b-25notification.htm.
- 2007-11-14: Form NT 10-Q; Period of report 2007-09-30; Description NOTIFICATION OF LATE FILING; Document d51533ntnt10vq.htm.
- 2005-05-17: Form NT 10-Q; Period of report 2005-03-31; Description FORM 12B25; Document lifeline12b25.txt.
- 2005-02-15: Form NT 10-Q; Period of report 2004-12-31; Description FORM 12B25; Document lifeline12b25.txt.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2016-11-10 | NT 10-Q | 2016-09-30 | NT 10-Q | lfvnform12b-25notification.htm |
| 2007-11-14 | NT 10-Q | 2007-09-30 | NOTIFICATION OF LATE FILING | d51533ntnt10vq.htm |
| 2005-05-17 | NT 10-Q | 2005-03-31 | FORM 12B25 | lifeline12b25.txt |
| 2005-02-15 | NT 10-Q | 2004-12-31 | FORM 12B25 | lifeline12b25.txt |
| 2004-08-12 | NT 10-Q | 2004-06-30 | Notification of late filing: quarterly report | nt10q604.txt |
| 2003-05-14 | NT 10-Q | 2003-03-31 | FORM 12B25 FOR MARCH 31, 2003 FORM 10-QSB | yaak10q12b25.htm |
| 2002-11-15 | NT 10-Q | 2002-09-30 | Notification of late filing: quarterly report | ext12b25yaakriver.txt |
| 2002-08-15 | NT 10-Q | 2002-06-30 | Notification of late filing: quarterly report | ext12b25yaakriver.txt |
| 1998-11-17 | NT 10-Q | 1998-09-30 | Notification of late filing: quarterly report |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |